Fish collagen peptides pass USD 440 million in 2026, on an 11.8% annual growth path2026 年鱼胶原蛋白肽市场突破 4.4 亿美元,年复合增长约 11.8%
Market research places the fish collagen peptides category at USD 443.49 million in 2026, up from USD 396.72 million in 2025, and projects USD 774.29 million by 2031 — a compound annual growth rate of 11.79%. The growth is described as a shift in demand toward higher-value collagen formats (pharmaceutical and clinical-grade uses, clean-label supplements) rather than bulk commodity supply.市场研究显示,鱼胶原蛋白肽品类规模由 2025 年的 3.9672 亿美元增至 2026 年的 4.4349 亿美元,预计到 2031 年达 7.7429 亿美元,年复合增长率为 11.79%。增长动力被描述为需求向更高价值的胶原蛋白形态(医药与临床级用途、清洁标签补充剂)转移,而非大宗商品供应。
What it means for buyers:对采购方的意义: For suppliers this means specification and documentation, not tonnage, increasingly decide who wins the order.对供应商而言,这意味着规格与文档而非吨位,越来越成为赢得订单的关键。